Editor in Chief Dr KK Aggarwal, Padma Shri Awardee Dated:1st September,2019
FDA recommends transitioning to duodenoscopes with disposable components to reduce risk of patient infection
The US Food and Drug Administration (FDA) has recommended that duodenoscope manufacturers and health care facilities transition to duodenoscopes with disposable components that may pose less risk to patient safety.
Specifically, because of challenges with cleaning these devices for reuse (reprocessing) and persistent high levels of contamination, the agency is recommending moving away from using duodenoscopes with fixed endcaps to those with disposable components that include disposable endcapsor to fully disposable duodenoscopes when they become available.
Disposable designs simplify or eliminate the need for reprocessing, which may reduce between-patient duodenoscope contamination as compared to reusable, or fixed endcaps.
Fixed endcap duodenoscopes have a plastic or rubber cap permanently glued to the metal edges around the distal end to prevent tissue injury from the metal edges on the scopes, but when permanently affixed, the endcaps also limit the accessibility to clean the crevices at the distal end.
The FDA is recommending health care facilities transition away from fixed endcap models including Olympus Corporation’s TJF-Q160, TJF-Q180V, PJF-160 and JF-140F; Fujifilm Medical Systems USA’s ED-530XT; and Pentax Medical’s ED-3490TK. The FDA has cleared two duodenoscopes with disposable end caps: Fujifilm Corporation, model ED-580XT and Pentax Medical, model ED34-i10T… (Source: US FDA)
An Open Letter to the Prime Minister to exclude doctors from the list of services in Consumer Protection Act, 2019
The medical fraternity has for long demanding the exclusion of the medical profession from the ambit of the Consumer Protection Act (CPA). Because CPA has reduced doctors to the status of mere “service providers” and patients have now become “consumers”, who now do not hesitate to resort to violence.
The Padma Awardee Doctors’ Forum had its annual meeting at India International Centre (IIC), New Delhi on Wednesday, August 28, 2019. The forum includes doctors in Delhi who have been honoured with the prestigious Padma Awards, among the highest civilian honors in India.
Our discussion primarily focused on the recently enacted Consumer Protection Act, 2019 and how it affects doctors and the medical profession all together. ....read more
Mera Bharat Mahan 17: Satsang
Satsang is a common household name and is generally attributed to that regular meeting of a group of elderly or women with a common intention of attaining inner happiness or peace through Bhajans or devotional songs. In Satsang, people realize that it is the Self, communing with Self.
The Sanskrit word ‘Satsang’ literally means gathering together for guidance, mutual support or in search of truth. It may involve talking together, eating together, working together, listening together or praying together. ....read more
Definition of Health
Health is not mere absence of disease; it is a state of physical, mental, social, spiritual, environmental and financial well-being. Allopathy does not define all aspects of health.
During MBBS, medical students are taught more about the physical health. Social and mental health are covered only in few lectures. Community health is a separate subject but never given its due importance. Spiritual health is not defined at all and financial health is hardly covered. ....read more
Healthcare News Monitor
New Delhi: Safdarjung Hospital has asked the central government to allow it to admit only one patient per bed, a practice followed by AIIMS and most private hospital to ensure quality service. The hospital made a representation to the Union health ministry on the matter recently in view of the increasing attacks on doctors by patients’ attendants for perceived neglect. Dr Sunil Gupta, Safdarjung Hospital’s medical superintendent, told TOI, “We follow a no-refusal policy. All patients coming to the casualty are admitted, regardless of availability of a bed. It is good for poor patients who have nowhere else to go, but admitting patients beyond the capacity affects the quality of service and leads to resentment among the patients and their families.” On Thursday, there was chaos at the hospital after a liver patient in his 50s died in the medicine emergency ward. His relatives accused the doctors of neglect and abused them. A young resident doctor — who wasn’t even involved in the patient’s treatment — was assaulted. “The resident doctor, a first year postgraduate student, was going for lunch with a senior after 24 hours at work. The mob attacked him and he suffered a fracture in the right arm, a contusion on the head and internal injuries,” said Dr Gupta.
ET Healthworld-TNN-Sushmi Dey
New Delhi: Compensation against adverse effects caused by faulty medical devices may not be part of the new draft law likely to be notified by health ministry in the next fortnight. Instead there may be a separate “quasi-judicial” system or entity developed outside the proposed legislation to look at ethical issues and compensation. The draft Biomedical Devices Regulation Bill – prepared by the government’s think tank Niti Aayog– aims to regulate a range of products from blood pressure monitoring machine to critical devices like stents and orthopedic implants and even diagnostics equipments and tests. Though Niti Aayog was in favour of introducing provisions for compensation in the bill, some other departments in the government have raised concerns about a possible conflict of interest if the regulator takes a call on judicial issues. “The final draft of the bill is ready and will be discussed in an inter-ministerial meeting by next week. After that it will be notified by the health ministry seeking public comments,” a senior official told TOI.
The Times of India- PTI
BEIJING: China's revised drug law, which removes drugs that are legal in foreign countries but not approved in China from the category of fake medicines, may allow entry of Indian generic medicines in the country, media reports said on Tuesday. China's top legislature, the Standing Committee of National People's Congress, passed the revised law on Monday to enhance management and supervision of the pharmaceutical market following numerous fake drugs and vaccine cases that had triggered a call for stronger measures to ensure drug safety. India has been demanding that China open its pharmaceutical market to Indian drugs as part of the efforts to lower the USD 57 billion trade deficit in about USD 95.5 billion total trade last year. No major Indian pharma company managed to establish itself in China in view of the rigid regulations and the costs involved. Legal foreign drugs, including generic drugs from India, will not be treated as fake medicine in China based on a revised drug administration law that will take effect on December 1, state-run Global Times reported. The latest revision removes drugs that are legal in foreign countries but not approved in China from the category of fake medicines.